Skip to main content
Erschienen in: Annals of Hematology 11/2020

12.09.2020 | Original Article

Hepatic and cardiac iron load as determined by MRI T2* in patients with congenital dyserythropoietic anemia type I

verfasst von: Mahdi Asleh, Aviva Levitas, Sharon Daniel, Abed Abu-Quider, Miriam Ben-Harosh, Joseph Kapelushnik

Erschienen in: Annals of Hematology | Ausgabe 11/2020

Einloggen, um Zugang zu erhalten

Abstract

Iron overload comprises one of the main complications of congenital dyserythropoietic anemia type I (CDA-I). When analyzing magnetic resonance imaging T2* (MRI T2*) results in CDA patients, two previous studies reported discordant results regarding iron load in these patients. To further understand iron loading pattern in this group of patients, we analyzed MRI T2* findings in 46 CDA-I patients. Mild to moderate hepatic iron overload was detected in 28/46 (60.8%) patients. A significant correlation was found between serum ferritin and liver iron concentration (LIC). A significant correlation (p value = 0.02) was also found between the patient’s age and LIC, reflecting increased iron loading over time, even in the absence of transfusion therapy. Notably, no cardiac iron overload was detected in any patient. Transfusion-naive patients had better LIC and better cardiac T2* values. These results demonstrate that a high percentage of CDA-I patients have liver iron concentration above the normal values, risking them with significant morbidity and mortality, and emphasize the importance of periodic MRI T2* studies for direct assessment of tissue iron concentration in these patients, taking age and transfusional burden into consideration.
Literatur
1.
Zurück zum Zitat Heimpel H, Schwarz K, Ebnöther M, Goede JS, Heydrich D, Kamp T, Plaumann L, Rath B, Roessler J, Schildknecht O, Schmid M, Wuillemin W, Einsiedler B, Leichtle R, Tamary H, Kohne E (2006) Congenital dyserythropoietic anemia type I (CDAI): molecular genetics, clinical appearance, and prognosis based on long-term observation. Blood. 107(1):334–340CrossRef Heimpel H, Schwarz K, Ebnöther M, Goede JS, Heydrich D, Kamp T, Plaumann L, Rath B, Roessler J, Schildknecht O, Schmid M, Wuillemin W, Einsiedler B, Leichtle R, Tamary H, Kohne E (2006) Congenital dyserythropoietic anemia type I (CDAI): molecular genetics, clinical appearance, and prognosis based on long-term observation. Blood. 107(1):334–340CrossRef
3.
Zurück zum Zitat Tamary H, Shalev H, Perez-Avraham G, Zoldan M, Levi I, Swinkels DW, Tanno T, Miller JL (2008) Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I. Blood. 112(13):5241–5244CrossRef Tamary H, Shalev H, Perez-Avraham G, Zoldan M, Levi I, Swinkels DW, Tanno T, Miller JL (2008) Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I. Blood. 112(13):5241–5244CrossRef
4.
Zurück zum Zitat Shalev H, Perez-Avraham G, Kapelushnik J, Levi I, Rabinovich A, Swinkels DW, Brasse-Lagnel C, Tamary H (2013) High levels of soluble serum hemojuvelin in patients with congenital dyserythropoietic anemia type I. Eur J Haematol 90(1):31–36CrossRef Shalev H, Perez-Avraham G, Kapelushnik J, Levi I, Rabinovich A, Swinkels DW, Brasse-Lagnel C, Tamary H (2013) High levels of soluble serum hemojuvelin in patients with congenital dyserythropoietic anemia type I. Eur J Haematol 90(1):31–36CrossRef
5.
Zurück zum Zitat Cappellini MD, Porter J, El-Beshlawy A, Li CK, Seymour JF, Elalfy M et al (2010) Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias. Haematologica. 95(4):557–566CrossRef Cappellini MD, Porter J, El-Beshlawy A, Li CK, Seymour JF, Elalfy M et al (2010) Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias. Haematologica. 95(4):557–566CrossRef
6.
Zurück zum Zitat Gary M (2011) Brittenham. Iron-chelating therapy for transfusional iron overload. N Engl J Med 364(15):1475–1477CrossRef Gary M (2011) Brittenham. Iron-chelating therapy for transfusional iron overload. N Engl J Med 364(15):1475–1477CrossRef
7.
Zurück zum Zitat Fischer R, Harmatz PR (2009) Non-invasive assessment of tissue iron overload. Hematology Am Soc Hematol Educ Program 2009:215–221CrossRef Fischer R, Harmatz PR (2009) Non-invasive assessment of tissue iron overload. Hematology Am Soc Hematol Educ Program 2009:215–221CrossRef
8.
Zurück zum Zitat Coates TD, Carson S, Wood JC, Berdoukas V (2016) Management of iron overload in hemoglobinopathies: what is the appropriate target iron level? Ann N Y Acad Sci 1368(1):95–106CrossRef Coates TD, Carson S, Wood JC, Berdoukas V (2016) Management of iron overload in hemoglobinopathies: what is the appropriate target iron level? Ann N Y Acad Sci 1368(1):95–106CrossRef
9.
Zurück zum Zitat Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, Firmin DN, Wonke B, Porter J, Walker JM, Pennell DJ (2001) Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 22(23):2171–2179CrossRef Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, Firmin DN, Wonke B, Porter J, Walker JM, Pennell DJ (2001) Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 22(23):2171–2179CrossRef
11.
Zurück zum Zitat Carpenter JP, He T, Kirk P, Roughton M, Anderson LJ, De Noronha SV et al (2011) On T2* magnetic resonance and cardiac iron. Circulation. 123(14):1519–1528CrossRef Carpenter JP, He T, Kirk P, Roughton M, Anderson LJ, De Noronha SV et al (2011) On T2* magnetic resonance and cardiac iron. Circulation. 123(14):1519–1528CrossRef
12.
Zurück zum Zitat Gandon Y, Olivié D, Guyader D, Aubé C, Oberti F, Sebille V, Deugnier Y (2004) Non-invasive assessment of hepatic iron stores by MRI. Lancet. 41(Pt 3):357–362CrossRef Gandon Y, Olivié D, Guyader D, Aubé C, Oberti F, Sebille V, Deugnier Y (2004) Non-invasive assessment of hepatic iron stores by MRI. Lancet. 41(Pt 3):357–362CrossRef
13.
Zurück zum Zitat Pennell DJ (2005) T2* magnetic resonance and myocardial iron in thalassemia. Ann N Y Acad Sci 1054:373–378CrossRef Pennell DJ (2005) T2* magnetic resonance and myocardial iron in thalassemia. Ann N Y Acad Sci 1054:373–378CrossRef
14.
Zurück zum Zitat Kwiatkowski JL, Kim HY, Thompson AA, Quinn CT, Mueller BU, Odame I, Giardina PJ, Vichinsky EP, Boudreaux JM, Cohen AR, Porter JB, Coates T, Olivieri NF, Neufeld EJ, for the Thalassemia Clinical Research Network (2012) Chelation use and iron burden in north American and British thalassemia patients: a report from the thalassemia longitudinal cohort. Blood. 119(12):2746–2753CrossRef Kwiatkowski JL, Kim HY, Thompson AA, Quinn CT, Mueller BU, Odame I, Giardina PJ, Vichinsky EP, Boudreaux JM, Cohen AR, Porter JB, Coates T, Olivieri NF, Neufeld EJ, for the Thalassemia Clinical Research Network (2012) Chelation use and iron burden in north American and British thalassemia patients: a report from the thalassemia longitudinal cohort. Blood. 119(12):2746–2753CrossRef
15.
Zurück zum Zitat Berdoukas V, Nord A, Carson S, Puliyel M, Hofstra T, Wood J et al (2013) Tissue iron evaluation in chronically transfused children shows significant levels of iron loading at a very young age. Am J Hematol 88(11):2–4CrossRef Berdoukas V, Nord A, Carson S, Puliyel M, Hofstra T, Wood J et al (2013) Tissue iron evaluation in chronically transfused children shows significant levels of iron loading at a very young age. Am J Hematol 88(11):2–4CrossRef
16.
Zurück zum Zitat Shalev H, Al-Athamen K, Levi I, Levitas A, Tamary H (2017) Morbidity and mortality of adult patients with congenital dyserythropoietic anemia type I. Eur J Haematol 98(1):13–18CrossRef Shalev H, Al-Athamen K, Levi I, Levitas A, Tamary H (2017) Morbidity and mortality of adult patients with congenital dyserythropoietic anemia type I. Eur J Haematol 98(1):13–18CrossRef
17.
Zurück zum Zitat Hankins JS, McCarville MB, Loeffler RB, Smeltzer MP, Onciu M, Hoffer FA et al (2009) R2* magnetic resonance imaging of the liver in patients with iron overload. Blood. 113(20):4853–4855CrossRef Hankins JS, McCarville MB, Loeffler RB, Smeltzer MP, Onciu M, Hoffer FA et al (2009) R2* magnetic resonance imaging of the liver in patients with iron overload. Blood. 113(20):4853–4855CrossRef
18.
Zurück zum Zitat Puliyel M, Sposto R, Berdoukas VA, Hofstra TC, Nord A, Carson S, Wood J, Coates TD (2014) Ferritin trends do not predict changes in total body iron in patients with transfusional iron overload. Am J Hematol 89(4):391–394CrossRef Puliyel M, Sposto R, Berdoukas VA, Hofstra TC, Nord A, Carson S, Wood J, Coates TD (2014) Ferritin trends do not predict changes in total body iron in patients with transfusional iron overload. Am J Hematol 89(4):391–394CrossRef
19.
Zurück zum Zitat Roghi A, Cappellini MD, Wood JC, Musallam KM, Patrizia P, Fasulo MR, Cesaretti C, Taher AT (2010) Absence of cardiac siderosis despite hepatic iron overload in Italian patients with thalassemia intermedia: an MRI T2* study. Ann Hematol 89(6):585–589CrossRef Roghi A, Cappellini MD, Wood JC, Musallam KM, Patrizia P, Fasulo MR, Cesaretti C, Taher AT (2010) Absence of cardiac siderosis despite hepatic iron overload in Italian patients with thalassemia intermedia: an MRI T2* study. Ann Hematol 89(6):585–589CrossRef
20.
Zurück zum Zitat Taher A, El Rassi F, Isma’eel H, Koussa S, Inati A, Cappellini MD (2008) Correlation of liver iron concentration determined by R2 magnetic resonance imaging with serum ferritin in patients with thalassemia intermedia. Haematologica. 93(10):1584–1586CrossRef Taher A, El Rassi F, Isma’eel H, Koussa S, Inati A, Cappellini MD (2008) Correlation of liver iron concentration determined by R2 magnetic resonance imaging with serum ferritin in patients with thalassemia intermedia. Haematologica. 93(10):1584–1586CrossRef
21.
Zurück zum Zitat Pakbaz Z, Fischer R, Fung E, Nielsen P, Harmatz P, Vichinsky E (2007) Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients. Pediatr Blood Cancer 49(3):329–332CrossRef Pakbaz Z, Fischer R, Fung E, Nielsen P, Harmatz P, Vichinsky E (2007) Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients. Pediatr Blood Cancer 49(3):329–332CrossRef
22.
Zurück zum Zitat Jensen PD, Jensen FT, Christensen T, Eiskjær H, Baandrup U, Nielsen JL (2003) Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool. Blood. 101(11):4632–4639CrossRef Jensen PD, Jensen FT, Christensen T, Eiskjær H, Baandrup U, Nielsen JL (2003) Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool. Blood. 101(11):4632–4639CrossRef
24.
Zurück zum Zitat Wood JC, Origa R, Agus A, Matta G, Coates TD, Galanello R (2008) Onset of cardiac iron loading in pediatric patients with thalassemia major. Haematologica. 93(6):917–920CrossRef Wood JC, Origa R, Agus A, Matta G, Coates TD, Galanello R (2008) Onset of cardiac iron loading in pediatric patients with thalassemia major. Haematologica. 93(6):917–920CrossRef
25.
Zurück zum Zitat Origa R, Barella S, Argiolas GM, Bina P, Agus A, Galanello R (2008) No evidence of cardiac iron in 20 neveror minimally-transfused patients with thalassemia intermedia. Haematologica. 93(7):1095–1096CrossRef Origa R, Barella S, Argiolas GM, Bina P, Agus A, Galanello R (2008) No evidence of cardiac iron in 20 neveror minimally-transfused patients with thalassemia intermedia. Haematologica. 93(7):1095–1096CrossRef
26.
Zurück zum Zitat Berdoukas V, Nord A, Carson S, Puliyel M, Hofstra T, Wood J et al (2013) Tissue iron evaluation in chronically transfused children shows significant levels of iron loading at a very young age. Am J Hematol 88(11):283–285CrossRef Berdoukas V, Nord A, Carson S, Puliyel M, Hofstra T, Wood J et al (2013) Tissue iron evaluation in chronically transfused children shows significant levels of iron loading at a very young age. Am J Hematol 88(11):283–285CrossRef
Metadaten
Titel
Hepatic and cardiac iron load as determined by MRI T2* in patients with congenital dyserythropoietic anemia type I
verfasst von
Mahdi Asleh
Aviva Levitas
Sharon Daniel
Abed Abu-Quider
Miriam Ben-Harosh
Joseph Kapelushnik
Publikationsdatum
12.09.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Annals of Hematology / Ausgabe 11/2020
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-020-04263-4

Weitere Artikel der Ausgabe 11/2020

Annals of Hematology 11/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.